20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Hinge Health, Inc. (HNGE) operates in the HEALTH INFORMATION SERVICES industry and is headquartered in San Francisco, United States with about 1,437 employees. Its market capitalization is roughly $8 billion. In the fiscal year ended 2025-12-31, HNGE reported $588M in revenue and ($528M) in net income.
Hinge Health, Inc. focuses on building a health system that scales and automates the delivery of care using technology. It designs its platform to address musculoskeletal system care (MSK), including acute injury, chronic pain, and post-surgical rehabilitation.
Interactive charts & full statements → Open the HNGE valuation workbench →
| Income statement | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|---|
| Total Revenue | $720M | $588M | $390M | $293M |
| Gross Profit | $609M | $469M | $301M | $194M |
| Gross Margin % | 84.5% | 79.8% | 77.0% | 66.3% |
| Operating Income (EBIT) | $94M | ($546M) | ($32M) | ($131M) |
| Operating Margin % | 13.0% | -92.9% | -8.2% | -44.6% |
| Net Income | $109M | ($528M) | ($12M) | ($108M) |
| Net Margin % | 15.2% | -89.9% | -3.1% | -36.9% |
| EBITDA | $103M | ($536M) | ($22M) | ($128M) |
| Earnings Per Share (EPS) | $1.31 | $-6.47 | $-0.15 | $-1.39 |
| Shares Outstanding (M) | 82M | 82M | 78M | 78M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $213M | $182M | $171M | $154M | $139M | $124M | $117M | $101M |
| Gross Profit | $184M | $154M | $144M | $126M | $98M | $100M | $96M | $79M |
| Gross Margin % | 86.4% | 84.6% | 84.5% | 81.9% | 70.3% | 81.0% | 82.0% | 78.8% |
| Operating Income (EBIT) | $40M | $32M | $27M | ($6M) | ($581M) | $13M | $21M | ($4M) |
| Operating Margin % | 19.0% | 17.6% | 16.0% | -4.0% | -417.4% | 10.6% | 17.8% | -3.8% |
| Net Income | $44M | $35M | $32M | ($2M) | ($576M) | $121M | $27M | $0M |
| Net Margin % | 20.5% | 19.3% | 18.8% | -1.2% | -413.8% | 98.0% | 23.1% | 0.3% |
| EBITDA | $45M | $33M | $30M | ($6M) | ($579M) | $14M | $23M | ($3M) |
| Earnings Per Share (EPS) | $0.53 | $0.43 | $0.38 | $-0.02 | $-7.38 | $1.55 | $0.35 | $0.00 |
| Shares Outstanding (M) | 82M | 82M | 85M | 79M | 78M | 78M | 78M | 78M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|---|
| Cash from Operations (CFO) | $291M | $171M | $49M | ($64M) |
| Capital Expenditures (CapEx) | $3M | $1M | $4M | $5M |
| Free Cash Flow (FCF) | $287M | $171M | $45M | ($69M) |
| FCF Margin % | 39.9% | 29.0% | 11.6% | -23.4% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $101M | $43M | $64M | $82M | $20M | $5M | $38M | $28M |
| Capital Expenditures (CapEx) | $2M | $0M | $0M | $1M | $2M | $1M | $1M | $0M |
| Free Cash Flow (FCF) | $100M | $43M | $63M | $81M | $18M | $4M | $37M | $28M |
| FCF Margin % | 46.8% | 23.6% | 37.2% | 52.7% | 13.2% | 3.4% | 31.8% | 27.9% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|---|
| Total Assets | $827M | $745M | $673M | $623M |
| Cash & Cash Equivalents | $286M | $208M | $301M | $235M |
| Total Liabilities | $483M | $366M | $257M | $195M |
| Total Debt (Short + Long-Term) | $4M | $4M | $4M | $5M |
| Total Shareholders' Equity | $344M | $379M | $417M | $427M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive HNGE viewer.
About TickerBase · Data methodology & sources · Privacy · Terms